JRS Pharma India is a wholly owned subsidiary of JRS Pharma, GMBH & Co.KG. Rettenmaier India Private Limited was incorporated in 2009, under the leadership of Mr. Rohit Raut (Managing Director), with a view to drive its pharmaceutical excipients business in India. Founded in 1878, the JRS Group has over 143 plus years of experience in the Excipients Domain. With 7 Research & Development Centers, 50 plus Production Facilities, 32 Sales Offices, a strong Technical Support Team and an award-winning Customer Service Team, we offer our customers the most cost-effective and quick time-to-market solutions. JRS Pharma has broadest array of excipients in the marketplace, with a wide portfolio of high functionality quality excipients designed for the global pharmaceutical and nutritional industry. Our technical expertise imparts excellent support to our customers, addresses their needs and formulation challenges. With the addition of a new Production Facility – Plant IV at JRS-GMW in Gujarat, India, we are market leaders to produce High Quality Microcrystalline Cellulose in India. Plant IV at JRS-GMW, Gujarat is a completely automated, state of the art facility, which has been modelled on the international manufacturing plants of JRS Group. We also produce super-disintegrants VIVASOL® and EXPLOTAB® at JRS-GMW Gujarat Plant II. All the production facilities are EXCiPACT certified and have all the regulatory certifications in place to support global regulatory filings. We have our Sales and Marketing Office in Thane and a 120,000 plus sq. ft. warehouse strategically located near Thane. We are your Ideal Partner in India for domestic and export driven supply. Please reach out to us on info@jrsindia.com and vijay.ahire@jrsindia.com
